421
Participants
Start Date
July 2, 2018
Primary Completion Date
March 12, 2020
Study Completion Date
March 12, 2020
Kosin University Gospel Hospital, Busan
Eulji University Hospital, Daejeon
Wonkwang University Hospital / Division of Rheumatology, Iksan
Kyung Hee University Hospital at Gangdong / Rheumatology, Seoul
Chonbuk National University Hospital, Jeonju
Ajou University Hospital, Department of Rheumatology, Suwon
Asan Medical Center, Songpa-gu
Hallym University Sacred Heart Hospital/Rheumatology, Internal Medicine, Anyang
Inje University Busan Paik Hospital, Department of Internal Medicine, Busan
Keimyung University Dongsan Medical Center, Daegu
Daegu Catholic University Medical Center, Department of Rheumatology, Daegu
Gacheon Medical School Gil Medical Center, Rheumatology, Internal Medicine, Incheon
Pusan National University Hospital, Pusan
Dong-A University Hospital, Pusan
Hanyang University Seoul Hospital, Seoul
Seoul National University Hospital, Seoul
Yonsei University Severance Hospital, Seoul
Kyung Hee University Hospital, Seoul
Hanyang University Hospital, Department of Rheumatology, Seoul
Catholic University of Korea, Kangnam St. Mary's Hospital, Seoul
Konkuk University Hospital, Department of Rheumatology, Seoul
Chung-Ang University Hospital, Seoul
Ewha Womans University Mokdong Hospital, Seoul
Lead Sponsor
Yonsei University
OTHER
Pfizer
INDUSTRY